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1 . Introduction 
Previous work demonstrated that the activity of 
glutamine phosphoribosylpyrophosphate (PRPP) 
amidotransferase (EC 2.4.2.14) was increased in all 
examined rat hepatomas [ 1,2] . The activity of this 
key purine biosynthetic enzyme is opposed by that 
of the rate-limiting enzyme of purine catabolism, 
xanthine oxidase (EC 1.2.3.2). This paper reports 
that xanthine oxidase activity was decreased in all 
hepatomas irrespective of growth rate or differentia- 
tion. Thus, in the liver tumors the ratio of the activity 
of amidotransferase/xanthine oxidase was markedly 
increased. This enzymatic imbalance, that yields a 
predominance of the synthetic over the opposing 
catabolic enzyme of purine metabolism, should confer 
selective advantages to the cancer cells. 
2. Materials and methods 
2.1. Animals and tissues 
The transplantable hepatomas of different growth 
rates were carried subcutaneously in inbred strains of 
male Buffalo or AU/N rats of 1 SO-250 g of weight. 
Normal rats of the same strain, sex, age and weight 
were sacrificed along with the tumor-bearing animals. 
The studies on regenerating liver and de;reloping rats, 
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the killing of animals and excision of livers and tumors 
were conducted as previously [ 31. The biological 
aspects [4] and biochemical properties [3] of the 
tumor lines in the spectrum of hepatomas of different 
growth rates were reported. 
2.2. Enzyme preparation 
5% homogenates (w/v) were prepared from normal 
liver and tumor tissues in 0.25 M sucrose. The homo- 
genate was centrifuged at 100 000 g for 30 min at 3°C 
in Beckman LS-50 preparative centrifuge. Uricase activ- 
ity (EC 1.7.3.3) was not present in the supernates; 
thus, it did not interfere with the xanthine oxidase 
assay. 
2.3. Assay system of xanthine oxidase 
A standard assay was developed which was an adap- 
tation of that of DeLamirande et al. [5] to the kinetic 
conditions of our rat liver and hepatoma systems. The 
supernate was preincubated for 40 min at 37°C and 
then added to the reaction mixture which contained 
in final concentrations: xanthine (0.17 mM); phosphate 
buffer (33 mM, pH 7.5); and a suitable amount of 
enzyme (supernate). The reaction was carried out at 
37°C and was stopped at 0 and 20 min by addition of 
0.1 ml of 100% (w/v) trichloroacetic acid. The mixture 
was centrifuged at 10 000 g for 15 min. In the clear 
supernates the uric acid produced from the substrate, 
xanthine, was measured by the increase in absorbancy 
at 293 nm, in a Gilford 2400s recording spectrophoto- 
meter. Blanks contained the identical reaction mixture 
without xanthine. The enzyme activity was provided 
by the difference between the rate in the complete 
reaction and that in the blank. Xanthine oxidase activ- 
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Table 1 
Decreased xanthine oxidase activity in hepatomas 
Tissues Growth 
rate 
(months) 
Xanthine oxidase 
activity -_- 
nmoles/h/mg 
protein X lo-’ 
Amidotransferase 
activity 
nmoles/h/mp 
protein X 10.’ 
Amido transfcrase/ 
xanthine oxidase 
ratios 
__. 
Normal liver (Buffalo) 
Control for 9618A 
Control for 20 
Control for 9618B 
Control for 16 
Control for 47C 
Control for 28A 
Control for 8999 
Control for 9633 
Control for 7800 
Normal liver (ACI/N) 
Control for 3924A 
Control for 3683 
Hepatomas 
9618A 
20 
9618B 
16 
47c 
28A 
8999 
9633 
7800 
3924A 
3683 
11.0 k 0.4 
7.8 -r 0.5 
7.0 + 0.3 
7.0 + 0.2 
10.8 + 0.7 
8.2 f 0.3 
10.8 + 0.4 
10.1 + 0.6 
9.0 f 0.4 
10.0 * 0.3 
10.9 + 0.4 
12.4 3.5 t 0.2 
(32)” 
11.6 3.9 -t 0.1 
(50)a 
10.8 1.1 i 0.1 
(16)” 
8.3 0.7 i 0.1 
(10)” 
7.1 2.3 * 0.1 
(22)” 
6.8 3.9 + 0.1 
(48)” 
6.3 5.4 t 0.2 
(50)” 
5.2 5.9 * 0.2 
(58)” 
1.2 5.5 ? 0.2 
(61)a 
0.9 1.0 + 0.1 
(10)” 
0.5 1.1 ?- 0.1 
(10)a 
5.5 t 0.7 
6.0 f 0.4 
5.5 f 0.4 
6.9 zr 0.5 
6.8 f 0.3 
5.5 * 0.4 
6.9 k 0.1 
7.3 + 0.3 
5.5 + 0.4 
0.5 + 0.02 
0.8 f 0.02 
0.8 f 0.01 
1.0 + 0.02 
0.6 + 0.01 
0.7 * 0.02 
0.6 + 0.03 
0.7 * 0.02 
0.6 t 0.02 
7.5 r 0.3 0.8 + 0.02 
5.4 + 0.4 0.5 t 0.02 
12.0 + 0.7 
(218)a 
13.0 t 0.6 
(217)” 
9.3 * 0.4 
(169)” 
10.1 f 0.6 
(146)” 
17.1 + 0.8 
(25 1)” 
9.6 ? 0.5 
(174)” 
22.0 + 0.6 
(319)” 
11.2 + 0.5 
(153)” 
13.9 f 0.7 
(253)” 
15.5 + 0.5 
(207)” 
15.1 + 0.9 
(280)” 
3.4 k 0.1 
(689)” 
3.3 f 0.1 
(412)a 
8.4 * 0.3 
(1050)” 
14.4 to.9 
(1469)” 
7.4 * 0.7 
(1333)” 
2.5 + 0.1 
(357)” 
4.0 I 0.5 
(666)” 
1.0 ?; 0.2 
(27 1)” 
2.7 * 0.2 
(450)” 
15.5 + 0.8 
(1937)” 
13.7 t 0.8 
(2740)” 
The data are given as means f S.E. of 4 to 10 rats in the various groups with percentages of corresponding 
control liver values in parentheses. The specific activities are to be multiplied by the exponential given to 
arrive at the actual values. Growth rate is expressed as the mean transplantation time in months between 
inoculation and growth to 1.5 cm diameter. 
aValues statistically significantly different from the respective controls (p < 0.05). 
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ity was calculated in pmoles uric acid produced per 
h/g wet weight of tissue and was expressed, as specific 
activity, in pmoles per h per mg protein. Through such 
investigations the optimum assay conditions and the 
various kinetic constants were established for the crude 
enzyme in liver and hepatomas. 
3. Results and discussion 
3.1. Comparison of properties of xanthine oxidase in 
normal liver and hepatomas 
Kinetic studies Cowed that the affinity of xanthine 
oxidase to the substrate, xanthine, was the same in 
normal liver and in slow- and rapidly-growing hepatomas 
(KM = 6 to 8 FM). For both liver and hepatoma the 
optimum pH was at 8.0; at pH = 7.4 the activity was 
approximately 80% of that at the pH optimum. Under 
our conditions xanthine oxidase activity was linear 
during 60-min incubation, and it was proportionate 
with amounts of protein of suljernate added over a 
range of 0.5 to 3.0 mg. 
rat liver and in hepatomas of different growth rates 
Table 1 shows that in normal liver the xanthinc 
3.2 Comparison of xanthine oxidase activity in normal 
oxidase specific activity ranged from 7.0 to 11.0 
pmol substrate metabolized per h per mg protein X 
lo-*. The specific activities in the slow, medium and 
rapidly growing hepatomas were 2- to lo-fold decreased. 
Since in the assays the enzyme activity was propor- 
tionate with enzyme amount, it is assumed that the 
decreased enzyme activity present in all the hepatomas 
represents decreased enzyme concentration in the 
tumors. 
Since xanthine oxidase is the rate-limiting enzyme 
of purine catabolism [S] , and glutamine PRPP amido- 
transferase a key enzyme of purine biosynthesis [6], 
it was of interest to examine the relationship of these 
two opposing key enzymes in the same hepatomas. 
As table 1 shows, for liver the specific activities were 
lower for amidotransferase than for xanthine oxidase. 
That the liver amidotransferase/xanthine oxidase ratios 
were low and unfavorable for de novo purine synthesis 
is underlined by the high K, of amidotransferase for 
the substrates, glutamine (KM = 1.7 mM) and PRPP 
(KM = 0.9 mM) [2], in contrast to that of xanthine 
oxidase for its substrate, xanthine (KM = 0.7 PM). Thus, 
in the reprogramming of gene expression that occurred 
in all hepatomas examined, the amidotransferase activ- 
ity increased, whereas xanthine oxidase activity 
decreased. In consequence, amidotransferase/xanthine 
ratios were increased to 2.7- to 27-fold of those in the 
corresponding normal liver. This reprogramming of gene 
expression snould confer selective advantages to the 
neoplastic cells. 
Previously we reported antagonistic behavior for 
opposing key enzymes in the hepatoma spectrum. The 
activities of key enzymes of glycolysis increased and 
those of gluconeogenesis decreased in parallel with the 
increase of tumor growth rate and malignancy [3]. 
Similar antagonistic behavior was recognized for activ- 
ities of DNA synthetic enzymes (DNA polymerase, 
ribonucleotide reductase, thymidine kinase) that 
increased and the rate-limiting degradative nzyme 
(dihydrouracil dehydrogenase) that increased with the 
rise in hepatoma growth rate [3]. This study demon- 
strates reciprocal behavior in gene expression manifest- 
ed in the activities of two opposing key enzymes that 
are increased in all hepatomas (amidotransferase) and 
decreased in all hepatomas (xanthine oxidase). 
3.3. Xan thine oxidase activity in regenerating and 
developing liver 
Xanthine oxidase activity in regenerating liver was 
not altered from that of the liver of sham-operated 
controls at 12, 24, 48,72 and 96 h after operation. 
Investigation in rats of different age groups showed 
that at 6 days post-natal age xanthine oxidase activity 
in the average liver cell was less than 5% of the activity 
of adult liver. The activity rose to 18,46, 76 and 94%, 
respectively, at post-natal age of 18, 25, 30 and 40 
days (fig. 1). 
3.4. Specificity to neoplasia of decreased xanthine 
oxidase activity in heputomas 
The decreased xanthine oxidase activity seems 
specific to neoplastic transformation in the liver and it 
does not merely indicate proliferation, because this 
activity did not change in regenerating liver. Since the 
decrease in enzyme activity occurred in all hepatomas 
irrespective of growth rate and degree of histological 
differentiation, this all-or-none behavior can be 
sharply contrasted with the differentiation-linked 
events that are expressed during post-natal development 
in normal liver (fig. 1). These results also underline the 
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Fig.1. Behavior of xanthine oxidase activity in developing 
liver. Activities were calculated per average ccl1 and expressed 
as percentages of the normal adult liver values. 
malignancy-linked nature of the imbalance in the 
ratios of amidotransferase/xanthine oxidase. 
The presently reported decrease in xanthine 
oxidase in 11 lines of hepatomas is in agreement with 
that observed in several types of primary and trans- 
plantable rodent neoplasms [5,6]. We also observed 
that in the MK-3 renal carcinoma xanthine oxidase 
specific activity was decreased to 50% of that of the 
kidney of control normal rats. Since the decreased 
xanthine oxidase activity is consistently associated with 
neoplasia, it has a relatively high probability of being 
an essential biochemical determinant of transformation. 
3.5. Mali@ancy-linked alterations: biological 
significance 
That xanthine oxidase activity was decreased in all 
the hepatomas, irrespective of the degree of malignancy, 
differentiation and growth rate, is important, since it 
suggests that the reprogramming of gene expression 
that occurs in malignant transformation is linked with 
a decrease in the expression of this key purine cataboliz- 
ing enzyme activity. In our laboratory recently we 
discovered in the hepatomas six such malignant trans- 
formation-linked alterations in enzyme activities and 
five of these relate to an increased potential in direct- 
ing of precursors to strategic biosynthetic processes. 
Thus, the increase in the activities of glucose 6-phos- 
phate dehydrogcnase and transaldolase provides an 
increased potential for channeling glycolytic inter- 
mediates into pentose phosphate biosynthesis [7]. The 
elevated UDP kinase activity should yield a higher capa- 
city for RNA and de novo DNA biosynthesis [S] . The 
increased adenylosuccinate synthetase activity should 
lead to increased IMP utilization for nucleic acid 
biosynthesis [9]. The high activity of glutamine PRPP 
amidotransferase should provide a heightened ability 
for de novo purine biosynthesis [ 1,2] . The sixth altera- 
tion observed in all hepatomas is the decrease in 
xanthine oxidase activity which depresses the ability to 
degrade purines. Thus, purines can be recycled for 
nucleic acid biosynthesis. These six enzymes may be 
used in the biochemical diagnosis of hepatomas as 
markers of neoplastic transformation and indicators of 
liver malignancy. 
4. Conclusions 
Xanthine oxidase was decreased 2- to 1 O-fold in all 
examined rat hepatomas irrespective of the malignancy, 
growth rate and degrees of histological differentiation 
of the neoplasms. The affinity to substrate (KM = 
6-8 PM) and the pH optimum (8.0) of the liver and 
hepatoma enzymes were the same. The reprogramming 
of gene expression, as manifested in the decreased 
activity of this key purine metabolizing enzyme, 
appears to be specific to neoplastic transformation. 
Since glutamine PRPP amidotransferase activity was 
increased but the opposing enzyme, xanthine oxidase, 
was decreased in all the hepatomas, the reprogramming 
of gene expression results in an imbalance that favors 
synthesis against catabolism. This enzymatic imbalance 
should confer selective advantages to the cancer cells. 
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